Back

Impact of ACLY on type 2 diabetes in UK Biobank: A Mendelian randomisation study

27 August 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Highlights from the Young on cutting edge therapy for lowering lipids Pharmacogenetics ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Alexander Stiby

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Lipid testing trends before and after hospitalization for myocardial infarction among adults in the U.S., 2008-2019
Ms C. Wiener (Durham, US)
Abstract Slides Video
Presentation thumbnail
The prevalence of statin intolerance worldwide: a systematic review and meta-analysis with 4,143,517 patients
Doctor I. Bytyci (Pristina, XK)
Abstract Slides Video
Presentation thumbnail
Target populations and treatment cost for bempedoic acid and PCSK9 inhibitors: a simulation study in a contemporary CAD cohort
Mr C. Blaum (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
Acute arterial events across all vascular territories in the FOURIER trial
Doctor K. Oyama (Sendai, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Highlights from the Young on cutting edge therapy for lowering lipids

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021
You may be interested in
thumbnail
Congress Presentation
Limited visibility and uptake of the clopidogrel pharmacogenomic guidelines among cardiologists
thumbnail
Congress Session
Pharmacogenetics: a tool to guide clinical decisions
thumbnail
Congress Presentation
CYP2C19 genetic variants and coronary atherosclerosis: insights beyond antiplatelet therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources